Shares of Akums Drugs and Pharmaceuticals Ltd surged more than 6% in trade after the company reported its consolidated results for the third quarter, showing steady growth in revenue and operating performance on a year-on-year basis.
For Q3, the company posted revenue of Rs 1,160 crore, up 14.8% from Rs 1,010 crore in the corresponding quarter last year. EBITDA rose 20.9% to Rs 147 crore compared to Rs 121 crore a year ago, reflecting improved operating efficiency. EBITDA margin expanded by 70 basis points to 12.7% from 12.0% in the year-ago period.
Net profit came in at Rs 66.3 crore, registering a 1.7% increase over Rs 65.2 crore reported in the same quarter last year.
Following the earnings announcement, the stock touched an intraday high of Rs 486.90, compared with the previous close of Rs 451.35, marking a gain of over 6% during the session. The stock opened at Rs 463.00 and hit a low of Rs 454.00 in early trade.
On the broader price trend, the stock has traded between a 52-week low of Rs 405.00 and a 52-week high of Rs 622.95, indicating volatility over the past year.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.